Skip to content

Bally's BALY Contingent Consideration Classified As Equity Fair Value Disclosure

Contingent Consideration Classified As Equity Fair Value Disclosure at other companies

Community Financial System logo
Community Financial SystemCBU
$225K-89.3%
LifeStance Health Group logo
LifeStance Health GroupLFST
-$1.01M
Tetra Tech logo
Tetra TechTTEK
$58K-97.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$15.79M-10.1%
Braze, Inc. logo
Braze, Inc.BRZE
$0
Provident Financial Services logo
Provident Financial ServicesPFS
$560K+28.4%

Other financials

Income statement

See full
Revenue$755.7M+105%
Operating income$91.6M+5,161%
Net income-$161.9M-569%
EPS (diluted)-$2.69-572%

Balance sheet

See full
Cash & equivalents$653.4M+183%
Total debt$6.8B+23.0%
Total equity$791.3M-0.6%
Total assets$10.9B+45.9%

Cash flow

See full
Operating cash flow-$145.0M-445%
CapEx$38.9M+27.6%
Free cash flow-$183.9M-1,693%

Valuation

See full
Market cap$707.8M+45.9%
Enterprise value$6.88B+18.6%
P/S0.2×-0.1×

Profitability

See full
Operating margin-4.2%-1.4pp
Net margin-25.3%+31.2pp
FCF margin-12%

Returns & leverage

See full
Return on equity-144%-434pp
Debt / equity8.6×+1.7×
Current ratio1.1×+0.4×

Where this comes from

Reported directly by Bally's in its filing.

Tagged under the XBRL concept us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure.

The official record: Bally's’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bally's's contingent consideration classified as equity fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bally's's contingent consideration classified as equity fair value disclosure?
Bally's (BALY) reported contingent consideration classified as equity fair value disclosure of $115M in Q1 2026.